NASDAQ:NBIX - Neurocrine Biosciences, Inc.
$78.43
 $-2.71
-3.34%
4:00PM EDT
2019-04-18
Neurocrine Biosciences, Inc. is engaged in discovering and developing pharmaceuticals, in diseases with unmet medical needs, through its research and development (R&D) platform, focused on neurological and endocrine based diseases and disorders. Its three lead late-stage clinical programs are elagolix, which is a gonadotropin-releasing hormone (GnRH) antagonist for endometriosis and uterine fibroids; INGREZZA (valbenazine), which is a vesicular monoamine transporter 2 (VMAT2) inhibitor, for the treatment of movement disorders, and opicapone, which is a selective catechol-O-methyltransferase inhibitor that is an adjunct therapy to preparations of levodopa/Dihydroxyphenylalanine (DOPA) decarboxylase inhibitors for adult patients with Parkinson's disease. Its product pipeline also includes NBI-640756, which targets tremor and NBI-74788, which targets classic congenital adrenal hyperplasia. Its R&D focus is on addressing diseases and disorders of the central nervous and endocrine systems. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  NBIX     avg for
industry  
  avg for
sector  
42 stocks weight:  387. 68   199. 07   233. 87  
42 stocks rank:  274. 00   1. 43 K 1. 06 K
# analyst opinions:  14. 00   14. 48   14. 09  
mean recommendation:  1. 80   2. 09   2. 01  

quick ratio:  8. 02   5. 29   1. 92  
current ratio:  8. 36   5. 64   2. 40  

ex-dividend date:     1995-12-28
target price low:  87. 00   84. 50   115. 74  
target price avg:  107. 57   110. 73   137. 39  
target price high:  127. 00   136. 41   157. 80  
1-yr high:  125. 85   114. 11   138. 85  
last close:  78. 43   87. 56   116. 78  
50-day avg:  83. 70   95. 43   123. 53  
200-day avg:  97. 03   94. 13   121. 20  
1-yr low:  68. 32   72. 67   98. 41  
volume:  517. 14 K 2. 43 M 4. 85 M
50-day avg volume:  763. 66 K 2. 72 M 4. 97 M
200-day avg volume:  901. 07 K 2. 90 M 4. 58 M

1-day return:  -3. 34 % -0. 40 % 0. 07 %
this week return:  -9. 06 % -5. 72 % -4. 11 %
12-wk return:  -13. 20 % 1. 78 % -0. 04 %
52-wk return:  14. 58 % 10. 81 % 14. 09 %

enterprise value (EV):  7. 57 B 51. 19 B 117. 96 B
market cap:  7. 12 B 43. 00 B 104. 52 B
EBITDA:  48. 62 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  155. 78   4. 34   13. 27  
enterprise/revenue (EV/R):  16. 78   68. 16   13. 68  
total revenue:  451. 24 M 10. 61 B 38. 24 B
total debt:  388. 50 M 12. 22 B 16. 66 B
debt/equity:  80. 81   46. 86   89. 46  
net income (common):  21. 11 M 2. 20 B 4. 21 B

shares outstanding:  90. 82 M 570. 91 M 1. 24 B
shares:  84. 69 M 571. 02 M 1. 23 B
shares short:  3. 70 M 9. 93 M 16. 79 M
shares short prior month:  4. 29 M 9. 96 M 16. 58 M
short ratio:  4. 59   5. 31   3. 30  
total cash/share:  7. 17   11. 13   9. 30  
total cash:  650. 91 M 6. 70 B 7. 10 B
free cash flow:  50. 88 M 3. 58 B 4. 74 B
operating cash flow:  101. 36 M 4. 14 B 6. 32 B

book value:  5. 29   12. 76   26. 84  
price/book:  14. 81   3. 08   -1. 74  
gross profits:  285. 83 M 8. 03 B 34. 77 B
operating margins:  9. 88 % -721. 97 % -88. 82 %
EBITDA margins:  10. 77 % 10. 94 % 22. 54 %
profit margins:  4. 68 % 7. 81 % 10. 60 %
gross margins:  87. 19 % 37. 02 % 55. 68 %

1-yr max volatility:  -13. 91 % --- ---
1-yr mean volatility:  0. 03 % 0. 03 % 0. 04 %

1-yr EPS:  0. 22   2. 39   4. 08  
forward EPS:  2. 69   3. 97   7. 14  
P/E:  356. 50   13. 59   22. 83  
forward P/E:  32. 06   -20. 05   14. 49  
PE/G:  5. 10   -1. 46   1. 68  
growth:  69. 88 % 126. 81 % 29. 29 %
earnings high:  0. 09   1. 02   1. 63  
earnings avg:  -0. 85   0. 76   1. 51  
earnings low:  -1. 40   0. 47   1. 39  
revenue high:  143. 50 M 2. 68 B 10. 71 B
revenue avg:  136. 72 M 2. 59 B 10. 49 B
revenue low:  127. 10 M 2. 49 B 10. 25 B
earnings growth:  161. 30 % 337. 80 % 56. 55 %
1-qtr earnings growth:  162. 20 % 147. 14 % 46. 20 %
return on assets:  3. 08 % -2. 80 % 5. 29 %
return on equity:  4. 95 % -18. 52 % 7. 38 %
revenue growth:  39. 10 % 92. 55 % 19. 15 %
revenue/share:  5. 00   13. 27   55. 24  

beta (1yr vs S&P500):  1. 35   1. 24   0. 93  
sharpe (1yr):  0. 19   0. 29   0. 60  

held % insiders:  1. 27 % 6. 38 % 3. 38 %
held % institutions:  105. 09 % 78. 60 % 68. 65 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-19 : NBIX
.    + 9.076 =         9.076 :: INITIAL WEIGHT
.   + 21.981 =        31.057 :: inverse volume-to-price addition
.   + 40.344 =        71.402 :: spline projection addition
.    x 3.558 =        254.07 :: 13 weeks' performance factor
.     x 1.02 =       259.226 :: one-year gains+dividend factor
.    x 1.432 =       371.218 :: industry recommendation factor
.    x 2.733 =      1014.477 :: symbol recommendation factor
.    x 1.246 =      1264.272 :: EV/R factor
.    x 2.477 =      3131.778 :: earnings growth factor
.    x 1.809 =      5665.142 :: return on assets factor
.    x 1.762 =      9979.957 :: return on equity factor
.    x 2.405 =     24001.188 :: revenue growth factor
.    x 2.517 =     60410.419 :: current ratio factor
.    x 1.069 =     64572.823 :: quick ratio factor
.    x 1.104 =     71260.577 :: short ratio factor
.    x 2.288 =    163055.816 :: price-to-book factor
.    x 1.129 =    184158.323 :: debt-to-equity factor
.    x 2.382 =     438741.85 :: EBITDA multiple vs industry factor
.    x 4.858 =   2131459.517 :: P/E weight
.    x 0.665 =   1418216.912 :: PE/G factor
.    x 1.412 =   2003168.891 :: beta factor
.    x 0.189 =    379198.594 :: sharpe factor
.    x 1.335 =    506089.356 :: target low factor
.    x 1.203 =    608916.936 :: target mean factor
.    x 1.079 =    656835.191 :: target high factor
.    x 1.312 =    861536.817 :: industry 2-weeks return factor
.    x 0.935 =    805825.131 :: "drift" penalty 4 days ago
.    x 0.944 =    760762.784 :: "drift" penalty 5 days ago
.      x 1.0 =    760523.974 :: overall "drift" factor
.    x 0.999 =    760084.987 :: largest single-day jump factor
.      x 1.0 =    759962.463 :: factor hist industry gain for week 15
.   cubeRoot =        91.257 :: reduced to standardize
.   + 38.282 =       129.539 :: upcoming earnings report
.  + 258.144 =       387.683 :: add/subtract for performance
.                    387.683 :: FINAL WEIGHT for NASDAQ:NBIX


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org